|
PAPOLG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.202200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.683400E-01 |
| Normal-vs-Stage2 |
9.803400E-01 |
| Normal-vs-Stage3 |
6.224600E-01 |
| Normal-vs-Stage4 |
3.392600E-01 |
| Stage1-vs-Stage2 |
8.119000E-01 |
| Stage1-vs-Stage3 |
3.373800E-01 |
| Stage1-vs-Stage4 |
1.449170E-01 |
| Stage2-vs-Stage3 |
7.274000E-01 |
| Stage2-vs-Stage4 |
4.907000E-01 |
| Stage3-vs-Stage4 |
6.293200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.886800E-01 |
| Normal-vs-AfricanAmerican |
4.658300E-02 |
| Normal-vs-Asian |
2.306000E-01 |
| Caucasian-vs-AfricanAmerican |
2.895600E-02 |
| Caucasian-vs-Asian |
3.512200E-01 |
| AfricanAmerican-vs-Asian |
4.874200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.396800E-01 |
| Normal-vs-Female |
9.095200E-01 |
| Male-vs-Female |
9.482600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.808200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.090000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.492400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.190640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.647400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.150000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.022600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.520400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.346770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.743160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.649200E-01 |
| Normal-vs-Grade 2 |
2.071000E-01 |
| Normal-vs-Grade 3 |
2.547000E-01 |
| Normal-vs-Grade 4 |
2.576400E-01 |
| Grade 1-vs-Grade 2 |
8.378200E-01 |
| Grade 1-vs-Grade 3 |
1.301200E-01 |
| Grade 1-vs-Grade 4 |
2.272400E-01 |
| Grade 2-vs-Grade 3 |
2.760600E-03 |
| Grade 2-vs-Grade 4 |
2.350100E-02 |
| Grade 3-vs-Grade 4 |
6.778200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.235800E-02 |
| Normal-vs-ccB subtype |
2.661600E-01 |
| ccA subtype-vs-ccB subtype |
1.221940E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.996800E-01 |
| Normal-vs-N1 |
9.722800E-01 |
| N0-vs-N1 |
9.075200E-01 |
|
|
